Houston, Texas October 6, 2009 – London American Risk Specialists, Inc. is pleased to congratulate our mutual Chapman & Associates client, Global Solutions for Infectious Diseases (GSID) for its work in the development of a new HIV preventative vaccine. According to newspaper articles published by the Los Angeles Times and Dallas Morning News, GSID recently announced that their clinical trials of this HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection and may certainly lead to the next generation of vaccines for AIDS.
Global Solutions for Infectious Diseases, a non-profit organization, is dedicated to changing the world through the development of low-cost effective solutions for the prevention of infectious diseases such as AIDS.
For more information concerning this topic please feel free to contact Mike Mullens at London American Risk Specialists, Dallas, Texas. 214-373-3936 (ext 206) or email mmullens@londonamericantx.com
Again, our heartfelt congratulations to Global Solutions for Infections Diseases for their tireless efforts to help make the world a healthier place.
Topics London
Was this article valuable?
Here are more articles you may enjoy.
Florida Needs More – Much More – Wind Mitigation, Say Experts at OIR Summit 
Viewpoint: Japan’s $550B Bet on America—What it Means for the US Insurance Market 
Carnival Cruise Passenger Served 14 Shots Awarded $300,000 After Fall Down Stairs 
Mustard Maker Caught Pumping Pollutants Into River for Years and Lying About It 
